330 related articles for article (PubMed ID: 37519583)
1. Orbital Mucormycosis: Understanding the Deadly Fungus Sweeping the Globe.
Farooq S; Khan NA; Singh A; Khan A; Sharma P; Meena R; Jakhar A; Kumar M; Kochar A
Cureus; 2023 Jun; 15(6):e41010. PubMed ID: 37519583
[TBL] [Abstract][Full Text] [Related]
2. Epidemiology, clinical profile, management, and outcome of COVID-19-associated rhino-orbital-cerebral mucormycosis in 2826 patients in India - Collaborative OPAI-IJO Study on Mucormycosis in COVID-19 (COSMIC), Report 1.
Sen M; Honavar SG; Bansal R; Sengupta S; Rao R; Kim U; Sharma M; Sachdev M; Grover AK; Surve A; Budharapu A; Ramadhin AK; Tripathi AK; Gupta A; Bhargava A; Sahu A; Khairnar A; Kochar A; Madhavani A; Shrivastava AK; Desai AK; Paul A; Ayyar A; Bhatnagar A; Singhal A; Nikose AS; Bhargava A; Tenagi AL; Kamble A; Nariani A; Patel B; Kashyap B; Dhawan B; Vohra B; Mandke C; Thrishulamurthy C; Sambare C; Sarkar D; Mankad DS; Maheshwari D; Lalwani D; Kanani D; Patel D; Manjandavida FP; Godhani F; Agarwal GA; Ravulaparthi G; Shilpa GV; Deshpande G; Thakkar H; Shah H; Ojha HR; Jani H; Gontia J; Mishrikotkar JP; Likhari K; Prajapati K; Porwal K; Koka K; Dharawat KS; Ramamurthy LB; Bhattacharyya M; Saini M; Christy MC; Das M; Hada M; Panchal M; Pandharpurkar M; Ali MO; Porwal M; Gangashetappa N; Mehrotra N; Bijlani N; Gajendragadkar N; Nagarkar NM; Modi P; Rewri P; Sao P; Patil PS; Giri P; Kapadia P; Yadav P; Bhagat P; Parekh R; Dyaberi R; Chauhan RS; Kaur R; Duvesh RK; Murthy R; Dandu RV; Kathiara R; Beri R; Pandit R; Rani RH; Gupta R; Pherwani R; Sapkal R; Mehta R; Tadepalli S; Fatima S; Karmarkar S; Patil SS; Shah S; Shah S; Shah S; Dubey S; Gandhi S; Kanakpur S; Mohan S; Bhomaj S; Kerkar S; Jariwala S; Sahu S; Tara S; Maru SK; Jhavar S; Sharma S; Gupta S; Kumari S; Das S; Menon S; Burkule S; Nisar SP; Kaliaperumal S; Rao S; Pakrasi S; Rathod S; Biradar SG; Kumar S; Dutt S; Bansal S; Ravani SA; Lohiya S; Ali Rizvi SW; Gokhale T; Lahane TP; Vukkadala T; Grover T; Bhesaniya T; Chawla U; Singh U; Une VL; Nandedkar V; Subramaniam V; Eswaran V; Chaudhry VN; Rangarajan V; Dehane V; Sahasrabudhe VM; Sowjanya Y; Tupkary Y; Phadke Y;
Indian J Ophthalmol; 2021 Jul; 69(7):1670-1692. PubMed ID: 34156034
[TBL] [Abstract][Full Text] [Related]
3. Analysis of COVID-19-associated rhino-orbital-cerebral mucormycosis patients in a tertiary care center in Northern India.
Yadav H; Sen S; Nath T; Mazumdar S; Jain A; Verma P; Gupta P
Indian J Ophthalmol; 2022 Jun; 70(6):2163-2168. PubMed ID: 35648004
[TBL] [Abstract][Full Text] [Related]
4. Is mucormycosis the end? A comprehensive management of orbit in COVID associated rhino-orbital-cerebral mucormycosis: preserving the salvageable.
Keshri A; Mathialagan A; Aishwarya A; Ravisankar ; Bhuskute G; Kanaujia V; Singh AK; Singh RK; Dhiman RK; Agarwal R
Eur Arch Otorhinolaryngol; 2023 Feb; 280(2):819-827. PubMed ID: 36053359
[TBL] [Abstract][Full Text] [Related]
5. Outcomes of transcutaneous retrobulbar Amphotericin B (TRAMB) as an adjuvant therapy for rhino-orbital-cerebral mucormycosis (ROCM) following COVID-19.
Shakrawal J; Sharma V; Goyal A; Kumar D; Meena S; Tiwari S; Jain V; Elhence P; Soni K; Choudhury B; Bhatnagar K; Garg MK; Misra S
Int Ophthalmol; 2023 Jun; 43(6):1919-1926. PubMed ID: 36427099
[TBL] [Abstract][Full Text] [Related]
6. Rhino-orbital mucormycosis following COVID-19 in previously non-diabetic, immunocompetent patients.
Nair AG; Adulkar NG; D'Cunha L; Rao PR; Bradoo RA; Bapaye MM; Kothari A; Dave TV; Shinde CA
Orbit; 2021 Dec; 40(6):499-504. PubMed ID: 34338124
[TBL] [Abstract][Full Text] [Related]
7. A fungal epidemic amidst a viral pandemic: Risk factors for development of COVID-19 associated rhino-orbital-cerebral mucormycosis in India.
Vasanthapuram VH; Gupta R; Adulkar N; Nair AG; Bradoo RA; Hegde R; Singh U; Tadepalli S; Mukherjee B; Kamal S; Alam MS; Rao R; Ananthakrishna S; Backiavathy V; Murthy AK; D'Cunha L; Dudeja G; Joji A; Kiran A; Koka K; Goswami Mukhopadhyay M; Nisar SP; Rao PR; Shinde CA
Orbit; 2023 Feb; 42(1):30-41. PubMed ID: 35192435
[TBL] [Abstract][Full Text] [Related]
8. Retrospective analysis of the role of retrobulbar amphotericin-B injection in the management of COVID-19 associated rhino-orbito-cerebral-mucormycosis.
Yadav R; Madan S; Rohatgi J; Ansari A; Sharma R; Gautam P; Rai P; Das GK; Sahu PK; Arora V
Pan Afr Med J; 2022; 42():312. PubMed ID: 36451988
[TBL] [Abstract][Full Text] [Related]
9. Rhino orbital cerebral mucormycosis in settings of COVID-19 infection: A case series of thirteen patients.
Verma R; Chakraborty R; Keerthiraj DB; Pal US
Natl J Maxillofac Surg; 2023; 14(2):311-316. PubMed ID: 37661985
[TBL] [Abstract][Full Text] [Related]
10. Clinical Presentations, Management and Outcomes of Rhino-Orbital-Cerebral Mucormycosis (ROCM) Following COVID-19: A Multi-Centric Study.
Dave TV; Gopinathan Nair A; Hegde R; Vithalani N; Desai S; Adulkar N; Kamal S; Mittal R; Bradoo RA
Ophthalmic Plast Reconstr Surg; 2021 Sep-Oct 01; 37(5):488-495. PubMed ID: 34314399
[TBL] [Abstract][Full Text] [Related]
11. Transcutaneous retrobulbar injection of amphotericin B in rhino-orbital-cerebral mucormycosis: a review.
Nair AG; Dave TV
Orbit; 2022 Jun; 41(3):275-286. PubMed ID: 34720026
[TBL] [Abstract][Full Text] [Related]
12. COVID-19-Associated Rhino-Orbital Mucormycosis in a Tertiary Health Care Center in Odisha, India.
Acharya S; Behera SK; Purohit S; Sahu A; Panda BB; Behera S
Cureus; 2023 Aug; 15(8):e43811. PubMed ID: 37731437
[TBL] [Abstract][Full Text] [Related]
13. COVID-19-Associated Mucormycosis in a Tertiary Care Hospital in India: A Case Series.
Singh S; Basera P; Anand A; Ozair A
Cureus; 2022 Aug; 14(8):e27906. PubMed ID: 36110469
[TBL] [Abstract][Full Text] [Related]
14. Rhino-orbital-cerebral mucormycosis: An epidemiological study from a tertiary care referral center in Western India.
Patel R; Jethva J; Bhagat PR; Prajapati V; Thakkar H; Prajapati K
Indian J Ophthalmol; 2022 Apr; 70(4):1371-1375. PubMed ID: 35326057
[TBL] [Abstract][Full Text] [Related]
15. Study of Profile of Mucormycosis During the Second Wave of COVID-19 in a Tertiary Care Hospital.
Kamath S; Kumar M; Sarkar N; Ahmed T; Sunder A
Cureus; 2022 Jan; 14(1):e21054. PubMed ID: 35155019
[TBL] [Abstract][Full Text] [Related]
16. Retrobulbar Injection of Amphotericin B in Patients With COVID-19 Associated Orbital Mucormycosis: A Systematic Review.
Sharifi A; Akbari Z; Shafie'ei M; Nasiri N; Sharifi M; Shafiei M; Zand A
Ophthalmic Plast Reconstr Surg; 2022 Sep-Oct 01; 38(5):425-432. PubMed ID: 35943425
[TBL] [Abstract][Full Text] [Related]
17. Rhino-Orbito-Cerebral-Mucormycosis During the COVID-19 Second Wave in 2021 - A Preliminary Report from a Single Hospital.
Arora R; Goel R; Khanam S; Kumar S; Shah S; Singh S; Chhabra M; Meher R; Khurana N; Sagar T; Kumar S; Garg S; Kumar J; Saxena S; Pant R
Clin Ophthalmol; 2021; 15():3505-3514. PubMed ID: 34429582
[TBL] [Abstract][Full Text] [Related]
18. Risk Factors of Rhino Orbital Mucormycosis.
Patade Y; G R
Cureus; 2022 Dec; 14(12):e33145. PubMed ID: 36721573
[TBL] [Abstract][Full Text] [Related]
19. Outcome of transcutaneous retrobulbar injection of liposomal amphotericin B in post-COVID-19 rhino-orbito-cerebral mucormycosis: Our experience.
Ramamurthy LB; Bhandari R; Kanakpur S; Thejaswini P
Indian J Ophthalmol; 2022 Mar; 70(3):1019-1024. PubMed ID: 35225564
[TBL] [Abstract][Full Text] [Related]
20. Clinicopathological Study of Mucormycosis in COVID-19 Patients: Experience From a Tertiary Care Center in South India.
Kandasamy S; Muthuraju S; Vasugi A; Chandrasekar M; Murugan R; Inbasekaran P; R P
Cureus; 2022 Mar; 14(3):e23016. PubMed ID: 35419223
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
